drugset / Trial / NCT01406158

A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation

NCT01406158

Phase 1 Completed 24 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

A study in healthy volunteers comparing two different liquid formulations of solifenacin with each other and with the tablet formulation.

Timeline

Start
2011-05
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule 10 mg Oral

Indications

No indication recorded.